Martingale Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,114
| Closed | -$1.86M | – | 824 |
|
|
2025
Q1 | $1.86M | Buy |
22,114
+120
| +0.5% | +$11.2K | 0.05% | 315 |
|
|
2024
Q4 | $2.03M | Buy |
21,994
+321
| +1% | +$30.9K | 0.05% | 311 |
|
|
2024
Q3 | $2.01M | Sell |
21,673
-11
| -0.1% | -$953 | 0.05% | 308 |
|
|
2024
Q2 | $1.78M | Sell |
21,684
-400
| -2% | -$29.4K | 0.04% | 321 |
|
|
2024
Q1 | $1.47M | Buy |
22,084
+600
| +3% | +$37K | 0.03% | 371 |
|
|
2023
Q4 | $1.22M | Sell |
21,484
-2
| -0% | -$105 | 0.02% | 404 |
|
|
2023
Q3 | $1.17M | Buy |
21,486
+1
| +0% | +$59 | 0.02% | 397 |
|
|
2023
Q2 | $1.45M | Buy |
21,485
+821
| +4% | +$50.1K | 0.03% | 347 |
|
|
2023
Q1 | $1.06M | Buy |
20,664
+2,200
| +12% | +$107K | 0.02% | 427 |
|
|
2022
Q4 | $850K | Buy |
18,464
+7
| +0% | +$328 | 0.02% | 501 |
|
|
2022
Q3 | $936K | Hold |
18,457
| – | – | 0.02% | 459 |
|
|
2022
Q2 | $842K | Sell |
18,457
-900
| -5% | -$40.3K | 0.02% | 508 |
|
|
2022
Q1 | $901K | Buy |
19,357
+299
| +2% | +$13.4K | 0.01% | 509 |
|
|
2021
Q4 | $958K | Hold |
19,058
| – | – | 0.01% | 507 |
|
|
2021
Q3 | $1.01M | Buy |
19,058
+10,451
| +121% | +$589K | 0.01% | 507 |
|
|
2021
Q2 | $526K | Sell |
8,607
-100
| -1% | -$5.31K | 0.01% | 574 |
|
|
2021
Q1 | $426K | Sell |
8,707
-200
| -2% | -$9.37K | ﹤0.01% | 658 |
|
|
2020
Q4 | $361K | Sell |
8,907
-34,300
| -79% | -$1.23M | ﹤0.01% | 707 |
|
|
2020
Q3 | $1.41M | Sell |
43,207
-46,300
| -52% | -$1.39M | 0.02% | 524 |
|
|
2020
Q2 | $2.36M | Hold |
89,507
| – | – | 0.03% | 474 |
|
|
2020
Q1 | $2.23M | Buy |
89,507
+17,501
| +24% | +$540K | 0.03% | 463 |
|
|
2019
Q4 | $2.59M | Buy |
72,006
+2,800
| +4% | +$96.6K | 0.03% | 533 |
|
|
2019
Q3 | $2.37M | Buy |
69,206
+13,402
| +24% | +$428K | 0.02% | 546 |
|
|
2019
Q2 | $1.56M | Sell |
55,804
-15,402
| -22% | -$428K | 0.02% | 654 |
|
|
2019
Q1 | $2.21M | Buy |
71,206
+1,900
| +3% | +$50.7K | 0.02% | 576 |
|
|
2018
Q4 | $1.64M | Buy |
69,306
+10,600
| +18% | +$290K | 0.02% | 588 |
|
|
2018
Q3 | $2.27M | Buy |
58,706
+2,600
| +5% | +$93.7K | 0.03% | 514 |
|
|
2018
Q2 | $1.88M | Buy |
56,106
+14,800
| +36% | +$527K | 0.02% | 564 |
|
|
2018
Q1 | $1.5M | Buy |
41,306
+29,206
| +241% | +$1.01M | 0.02% | 622 |
|
|
2017
Q4 | $386K | Sell |
12,100
-38,001
| -76% | -$1.3M | 0.01% | 857 |
|
|
2017
Q3 | $1.88M | Sell |
50,101
-9,510
| -16% | -$324K | 0.03% | 569 |
|
|
2017
Q2 | $1.86M | Sell |
59,611
-5,696
| -9% | -$164K | 0.03% | 567 |
|
|
2017
Q1 | $1.61M | Hold |
65,307
| – | – | 0.02% | 598 |
|
|
2016
Q4 | $1.66M | Buy |
65,307
+5,000
| +8% | +$111K | 0.02% | 598 |
|
|
2016
Q3 | $1.2M | Buy |
60,307
+46,000
| +322% | +$804K | 0.02% | 641 |
|
|
2016
Q2 | $205K | Hold |
14,307
| – | – | ﹤0.01% | 806 |
|
|
2016
Q1 | $223K | Buy |
+14,307
| New | +$205K | ﹤0.01% | 766 |
|
Other funds holding LMAT
CCA
CCM
GCM
CAM
RIM
Martingale Asset Management's LMAT Position: Q2 2025 in Review
Martingale Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 22,114 shares — an estimated $1.86M sold.
Martingale Asset Management first reported a position in LMAT in Q1 2016 and held it in 37 quarters. The position peaked at $2.59M in Q4 2019. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.
- Martingale Asset Management reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
- Martingale Asset Management sold 22,114 LeMaitre Vascular shares in Q2 2025, an estimated $1.86M.
- Martingale Asset Management first reported a position in LeMaitre Vascular in Q1 2016 and held it in 37 quarters.
- Martingale Asset Management's LeMaitre Vascular position peaked at $2.59M in Q4 2019.
- 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.
Based on Martingale Asset Management's 13F filing for Q2 2025, filed 11 Aug 2025.